Beherasco, Aida F.
HRN: 21-30-45 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/07/2022
CEFUROXIME 750MG (VIAL)
05/07/2022
05/08/2022
IV
750mg
3 Doses
S/P TAHBSO
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft TissueIntra-abdominal Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: No Wrong Dose Wrong Dose
Overall appropriateness: No Wrong Dose